{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:41:58Z","timestamp":1770151318331,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.intimp.2025.114426","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:12:47Z","timestamp":1741464767000},"page":"114426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Research progress of DNA methylation in the diagnosis and treatment of thyroid carcinoma"],"prefix":"10.1016","volume":"152","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deyu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sufang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0005","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0010","doi-asserted-by":"crossref","first-page":"15","DOI":"10.25122\/jml-2023-0270","article-title":"WHO 2022 updates on follicular cell and c-cell derived thyroid neoplasm","volume":"17","author":"Goswami","year":"2024","journal-title":"J. Med. Life"},{"issue":"9","key":"10.1016\/j.intimp.2025.114426_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29076","article-title":"Differentiated thyroid carcinoma in children: A retrospective analysis of 125 pediatric cases from a single institution in India","volume":"68","author":"Thankamony","year":"2021","journal-title":"Pediatr. Blood Cancer"},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0020","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3390\/biom12030417","article-title":"DNA methylation malleability and dysregulation in Cancer progression: understanding the role of PARP1","volume":"12","author":"Srivastava","year":"2022","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1186\/s12935-021-02405-w","article-title":"Epigenetic modification and BRAF gene mutation in thyroid carcinoma","volume":"21","author":"Huang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12957-023-03240-1","article-title":"Role of hypermethylated SLC5A8 in follicular thyroid cancer diagnosis and prognosis prediction","volume":"21","author":"Yang","year":"2023","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.intimp.2025.114426_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1474267","article-title":"The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer","volume":"14","author":"Sabi","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.114426_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.736068","article-title":"Integrative analysis of DNA methylation and gene expression identified follicular thyroid Cancer-specific diagnostic biomarkers","volume":"12","author":"Yao","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"23","key":"10.1016\/j.intimp.2025.114426_bb0045","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2217\/epi-2023-0338","article-title":"RUNX1 methylation as a cancer biomarker in differentiating papillary thyroid cancer from benign thyroid nodules","volume":"15","author":"Li","year":"2023","journal-title":"Epigenomics"},{"key":"10.1016\/j.intimp.2025.114426_bb0050","article-title":"TERT promoter methylation is associated with high expression of TERT and poor prognosis in papillary thyroid cancer","volume":"14","author":"Li","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/15592294.2023.2192894","article-title":"DNA hypomethylation mediates immune response in pan-cancer","volume":"18","author":"Zhang","year":"2023","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.intimp.2025.114426_bb0060","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3390\/biomedicines12040712","article-title":"Molecular pathology of thyroid tumors: essential points to comprehend regarding the latest WHO classification","volume":"12","author":"Chiba","year":"2024","journal-title":"Biomedicines"},{"issue":"Suppl. 12","key":"10.1016\/j.intimp.2025.114426_bb0065","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1471-2164-16-S12-S7","article-title":"A novel analysis strategy for integrating methylation and expression data reveals core pathways for thyroid cancer aetiology","volume":"16","author":"Ozer","year":"2015","journal-title":"BMC Genomics"},{"issue":"2","key":"10.1016\/j.intimp.2025.114426_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1089\/thy.2019.0011","article-title":"Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer","volume":"30","author":"Park","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/j.intimp.2025.114426_bb0075","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fgene.2020.00294","article-title":"Methylation-driven genes identified as novel prognostic indicators for thyroid carcinoma","volume":"11","author":"Lv","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.intimp.2025.114426_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2024.108640","article-title":"Therapeutic targeting of DNA methylation alterations in cancer","volume":"258","author":"Lee","year":"2024","journal-title":"Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.intimp.2025.114426_bb0085","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1089\/thy.2021.0662","article-title":"Thyroid Cancer incidence and mortality trends in the United States: 2000-2018","volume":"32","author":"Megwalu","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/j.intimp.2025.114426_bb0090","series-title":"Global Cancer Observatory: Cancer Today","author":"Ferlay","year":"2024"},{"key":"10.1016\/j.intimp.2025.114426_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-0716-2505-7_1","article-title":"Papillary thyroid carcinoma: current position in epidemiology, genomics, and classification","volume":"2534","author":"Lam","year":"2022","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0100","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12022-021-09666-1","article-title":"Molecular pathology of non-familial follicular epithelial-derived thyroid Cancer in adults: from RAS\/BRAF-like tumor designations to molecular risk stratification","volume":"32","author":"Soares","year":"2021","journal-title":"Endocr. Pathol."},{"issue":"1 Suppl","key":"10.1016\/j.intimp.2025.114426_bb0105","first-page":"338","article-title":"Endocrine gland cancer","volume":"75","author":"Correa","year":"1995","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.intimp.2025.114426_bb0110","article-title":"Follicular thyroid carcinoma in a developing country: A 10-year retrospective study","volume":"13","author":"Aziz","year":"2021","journal-title":"Cureus"},{"issue":"8","key":"10.1016\/j.intimp.2025.114426_bb0115","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.intimp.2025.114426_bb0120","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.21037\/tcr-23-1526","article-title":"Synchronous papillary and follicular thyroid carcinomas: the first retrospective cohort study and literature review","volume":"13","author":"Ye","year":"2024","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0125","first-page":"256","article-title":"Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance","volume":"49","author":"Liu","year":"2020","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr. Pathol."},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0135","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/thy.2020.0944","article-title":"2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer","volume":"31","author":"Bible","year":"2021","journal-title":"Thyroid"},{"issue":"739","key":"10.1016\/j.intimp.2025.114426_bb0140","first-page":"962","article-title":"Carcinome anaplasique de la thyro\u00efde\u202f: nouvelles approches th\u00e9rapeutiques [Anaplastic thyroid carcinoma: new therapeutic approaches]","volume":"17","author":"Stamatiou","year":"2021","journal-title":"Rev. Med. Suisse"},{"key":"10.1016\/j.intimp.2025.114426_bb0145","series-title":"The MD Anderson surgical oncology handbook","first-page":"463","article-title":"Carcinoma of the thyroid gland and neoplasms of the parathyroid glands","author":"Long","year":"2018"},{"issue":"7","key":"10.1016\/j.intimp.2025.114426_bb0150","article-title":"Medullary thyroid carcinoma: a unique case report","volume":"16","author":"Sumithra","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.intimp.2025.114426_bb0155","first-page":"82","article-title":"Effect of non-invasive follicular thyroid neoplasm with papillary-like features (NIFTP) terminology on surgical management concepts","volume":"56","author":"Abdelwahab","year":"2023","journal-title":"Rev. Esp. Patol."},{"issue":"52","key":"10.1016\/j.intimp.2025.114426_bb0160","doi-asserted-by":"crossref","first-page":"33700","DOI":"10.1073\/pnas.2011361117","article-title":"DNA methylation mutants in Physcomitrella patens elucidate individual roles of CG and non-CG methylation in genome regulation","volume":"117","author":"Domb","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"8","key":"10.1016\/j.intimp.2025.114426_bb0165","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1021\/bi301319y","article-title":"Most methylation-susceptible DNA sequences in human embryonic stem cells undergo a change in conformation or flexibility upon methylation","volume":"52","author":"Shimooka","year":"2013","journal-title":"Biochemistry"},{"issue":"16","key":"10.1016\/j.intimp.2025.114426_bb0170","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/bioinformatics\/btn256","article-title":"Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cells","volume":"24","author":"Li","year":"2008","journal-title":"Bioinformatics"},{"issue":"6","key":"10.1016\/j.intimp.2025.114426_bb0175","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2217\/epi.12.55","article-title":"CG methylation","volume":"4","author":"Vinson","year":"2012","journal-title":"Epigenomics"},{"issue":"9","key":"10.1016\/j.intimp.2025.114426_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0291202","article-title":"Herbivory induced methylation changes in the Lombardy poplar: A comparison of results obtained by epiGBS and WGBS","volume":"18","author":"Troyee","year":"2023","journal-title":"PLoS ONE"},{"key":"10.1016\/j.intimp.2025.114426_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbi.2024.102593","article-title":"Dynamics of DNA methylation and its impact on plant embryogenesis","volume":"81","author":"Frost","year":"2024","journal-title":"Curr. Opin. Plant Biol."},{"key":"10.1016\/j.intimp.2025.114426_bb0190","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13072-017-0130-8","article-title":"DNA methylation and DNA methyltransferases","volume":"10","author":"Edwards","year":"2017","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"10.1016\/j.intimp.2025.114426_bb0195","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1093\/nar\/gkw1258","article-title":"Non-CpG methylation by DNMT3B facilitates REST binding and gene silencing in developing mouse hearts","volume":"45","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.114426_bb0200","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7150\/ijbs.11218","article-title":"DNA methylation, its mediators and genome integrity","volume":"11","author":"Meng","year":"2015","journal-title":"Int. J. Biol. Sci."},{"issue":"17","key":"10.1016\/j.intimp.2025.114426_bb0205","doi-asserted-by":"crossref","first-page":"8469","DOI":"10.1158\/0008-5472.CAN-06-1547","article-title":"Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation","volume":"66","author":"Cadieux","year":"2006","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0210","first-page":"96","article-title":"FOXA1 positively regulates gene expression by changing gene methylation status in human breast cancer MCF-7 cells","volume":"8","author":"Zheng","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0215","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.yexcr.2013.11.009","article-title":"Epigenetic inactivation of SPINT2 is associated with tumor suppressive function in esophageal squamous cell carcinoma","volume":"322","author":"Yue","year":"2014","journal-title":"Exp. Cell Res."},{"issue":"12","key":"10.1016\/j.intimp.2025.114426_bb0220","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1089\/thy.2023.0157","article-title":"Methylation-mediated silencing of ATF3 promotes thyroid cancer progression by regulating prognostic genes in the MAPK and PI3K\/AKT pathways","volume":"33","author":"Xiao","year":"2023","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.intimp.2025.114426_bb0225","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000516122","article-title":"RAP1GAP functions as a tumor suppressor gene and is regulated by DNA methylation in differentiated thyroid cancer","volume":"161","author":"Faam","year":"2021","journal-title":"Cytogenet. Genome Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.114426_bb0230","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/ERC-21-0297","article-title":"TREM1 fosters an immunosuppressive tumor microenvironment in papillary thyroid cancer","volume":"29","author":"Zhao","year":"2022","journal-title":"Endocr. Relat. Cancer"},{"issue":"9","key":"10.1016\/j.intimp.2025.114426_bb0235","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1210\/clinem\/dgae141","article-title":"MeIS: DNA methylation-based immune response signatures for thyroid nodule diagnostics","volume":"109","author":"Chen","year":"2024","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.intimp.2025.114426_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.676449","article-title":"MeImmS: predict clinical benefit of anti-PD-1\/PD-L1 treatments based on DNA methylation in non-small cell lung cancer","volume":"12","author":"Shang","year":"2021","journal-title":"Front. Genet."},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0245","doi-asserted-by":"crossref","first-page":"171","DOI":"10.34172\/aim.2022.29","article-title":"CpG island methylation of the Rap1Gap gene in medullary thyroid cancer","volume":"25","author":"Faam","year":"2022","journal-title":"Arch. Iran. Med."},{"issue":"7","key":"10.1016\/j.intimp.2025.114426_bb0250","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1210\/jc.2012-3566","article-title":"DNA methylation signatures identify biologically distinct thyroid cancer subtypes","volume":"98","author":"Rodr\u00edguez-Rodero","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"10.1016\/j.intimp.2025.114426_bb0255","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1089\/thy.2018.0198","article-title":"Comprehensive transcriptomic and genomic profiling of subtypes of follicular variant of papillary thyroid carcinoma","volume":"28","author":"Song","year":"2018","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.intimp.2025.114426_bb0260","first-page":"1090","article-title":"Classification of thyroid tumors based on DNA methylation patterns","volume":"33","author":"Marczyk","year":"2023","journal-title":"Thyroid"},{"issue":"2","key":"10.1016\/j.intimp.2025.114426_bb0265","doi-asserted-by":"crossref","first-page":"477","DOI":"10.21037\/tcr.2019.11.38","article-title":"Identification of key candidate genes and pathways in follicular variant papillary thyroid carcinoma by integrated bioinformatical analysis","volume":"9","author":"Jing","year":"2020","journal-title":"Transl. Cancer Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.114426_bb0270","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/ERC-11-0212","article-title":"Genome-wide alterations in gene methylation by the BRAF V600E mutation in papillary thyroid cancer cells","volume":"18","author":"Hou","year":"2011","journal-title":"Endocr. Relat. Cancer"},{"issue":"8","key":"10.1016\/j.intimp.2025.114426_bb0275","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1139\/gen-2020-0178","article-title":"Genomic DNA methylation analysis reveals that BLNK is a key potential gene in the regulation of autophagy-related thyroid cancer progression","volume":"64","author":"Zhang","year":"2021","journal-title":"Genome"},{"issue":"2","key":"10.1016\/j.intimp.2025.114426_bb0280","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/CBM-190871","article-title":"Alterations of regulatory factors and DNA methylation pattern in thyroid cancer","volume":"28","author":"Iancu","year":"2020","journal-title":"Cancer Biomark."},{"issue":"4","key":"10.1016\/j.intimp.2025.114426_bb0285","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.108510","article-title":"NOL4 is downregulated and hyper-methylated in papillary thyroid carcinoma suggesting its role as a tumor suppressor gene","volume":"18","author":"Sheikholeslami","year":"2020","journal-title":"Int. J. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0290","first-page":"634","article-title":"The epigenetic modification of SLC5A8 in papillary thyroid carcinoma and its effects on clinic-pathological features","volume":"51","author":"Sheikholeslami","year":"2022","journal-title":"Iran. J. Public Health"},{"issue":"4","key":"10.1016\/j.intimp.2025.114426_bb0295","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1210\/clinem\/dgaa950","article-title":"DNA methylation haplotype block markers efficiently discriminate follicular thyroid carcinoma from follicular adenoma","volume":"106","author":"Zhang","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.intimp.2025.114426_bb0300","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1002\/jcp.29591","article-title":"Hypermethylated RASSF1 and SLC5A8 promoters alongside BRAF mutation as biomarkers for papillary thyroid carcinoma","volume":"235","author":"Khatami","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2025.114426_bb0305","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/cen.14192","article-title":"Diagnostic significance of DNA methylation of PTEN and DAPK in thyroid tumors","volume":"93","author":"Wei","year":"2020","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.intimp.2025.114426_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104497","article-title":"Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma","volume":"90","author":"Hong","year":"2023","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.intimp.2025.114426_bb0315","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032928","article-title":"Diagnostic value of cell-free DNA in thyroid cancer: A systematic review and meta-analysis","volume":"102","author":"Hou","year":"2023","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2025.114426_bb0320","article-title":"Single-cell RNA sequencing revealed a 3-gene panel predicted the diagnosis and prognosis of thyroid papillary carcinoma and associated with tumor immune microenvironment","volume":"12","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.intimp.2025.114426_bb0325","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13040-018-0184-6","article-title":"Combining DNA methylation and RNA sequencing data of cancer for supervised knowledge extraction","volume":"11","author":"Cappelli","year":"2018","journal-title":"BioData Min"},{"issue":"1","key":"10.1016\/j.intimp.2025.114426_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/CBM-182265","article-title":"Methylation of tumour suppressor genes associated with thyroid cancer","volume":"25","author":"Botezatu","year":"2019","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.intimp.2025.114426_bb0335","series-title":"Methylation-Driven Gene PLAU as a Potential Prognostic Marker for Differential Thyroid","author":"Wu","year":"2022"},{"key":"10.1016\/j.intimp.2025.114426_bb0340","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.646793","article-title":"Analysis of the prognostic value and potential molecular mechanisms of TREM-1 overexpression in papillary thyroid Cancer via bioinformatics methods","volume":"12","author":"Xie","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"19","key":"10.1016\/j.intimp.2025.114426_bb0345","doi-asserted-by":"crossref","first-page":"7183","DOI":"10.1002\/cam4.3388","article-title":"A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma","volume":"9","author":"Chen","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.intimp.2025.114426_bb0350","doi-asserted-by":"crossref","first-page":"1686316","DOI":"10.1155\/2022\/1686316","article-title":"Identification and validation of a prognostic signature based on methylation profiles and methylation-driven gene DAB2 as a prognostic biomarker in differentiated thyroid carcinoma","volume":"2022","author":"Ju","year":"2022","journal-title":"Dis. Markers"},{"key":"10.1016\/j.intimp.2025.114426_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.990301","article-title":"Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer","volume":"13","author":"Zhou","year":"2022","journal-title":"Front. Genet."},{"issue":"13","key":"10.1016\/j.intimp.2025.114426_bb0360","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.3390\/cancers15133449","article-title":"Analysis of expression of programmed cell death ligand 1 (PD-L1) and BRAFV600E mutation in thyroid cancer","volume":"15","author":"Sekino","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0365","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.7150\/thno.50333","article-title":"From biomarkers to therapeutic targets: the promise of PD-L1 in thyroid autoimmunity and cancer","volume":"11","author":"D\u2019Andr\u00e9a","year":"2021","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.intimp.2025.114426_bb0370","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.surg.2013.07.009","article-title":"Potential role of 5-aza-2\u2032-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer","volume":"154","author":"Gunda","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.intimp.2025.114426_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107271","article-title":"Dual inhibitors of DNMT and HDAC remodels the immune microenvironment of colorectal cancer and enhances the efficacy of anti-PD-L1 therapy","volume":"206","author":"Yang","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2025.114426_bb0380","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.736068","article-title":"Integrative analysis of DNA methylation and gene expression identified follicular thyroid Cancer-specific diagnostic biomarkers","volume":"12","author":"Yao","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.intimp.2025.114426_bb0385","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3892\/mco.2022.2574","article-title":"Epithelial-to-mesenchymal transition of circulating tumor cells and CD133 expression on predicting prognosis of thyroid cancer patients","volume":"17","author":"Li","year":"2022","journal-title":"Mol. Clin. Oncol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925004163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T05:07:58Z","timestamp":1757912878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925004163"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":77,"alternative-id":["S1567576925004163"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114426","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress of DNA methylation in the diagnosis and treatment of thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.114426","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114426"}}